Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
DLH Holdings Corp. announced it will release its fiscal third quarter 2026 financial results on July 29, 2026, after market close. The company will host a conference call on July 30, 2026, to discuss the results and operating trends with senior management. The call includes a presentation and a Q&A session, with materials available on the company's…
Outdoor Holding Company (NASDAQ: POWW/POWWP), owner of GunBroker.com, will release its financial results for the first quarter of fiscal year 2027 premarket on August 10, 2026, followed by a management conference call to discuss performance and corporate updates.
Kalaris Therapeutics has appointed Liisa Bayko, an experienced biotechnology finance leader and analyst, as Chief Financial Officer. This strategic hire strengthens the leadership team during the ongoing Phase 1b/2 clinical trial of TH103, a novel biologic targeting neovascular age-related macular degeneration and other retinal diseases. Bayko's ex…
LM Funding America, Inc. is changing its corporate name to PowerCompute, Inc. to reflect its strategic focus on leveraging its 26 megawatts of wholly-owned power infrastructure for high-performance computing (HPC), artificial intelligence (AI) infrastructure, and Bitcoin mining. The company's common stock will trade under the new ticker symbol PWCM…
Terra Innovatum Global has signed a Letter of Intent with Waiken ILW for initial deployment of up to 8 MWe of its SOLO™ micro-modular nuclear reactors to support DIRECTV Latin America's data center infrastructure in Argentina and Brazil. This agreement reflects growing demand for clean, reliable behind-the-meter energy solutions in critical infrast…
Collegium Pharmaceutical announced plans to move its corporate headquarters to One Lincoln in downtown Boston in early 2027. This move aligns with the company's evolution as a diversified biopharmaceutical firm and strengthens its ties to the Massachusetts healthcare and life sciences ecosystem, fostering collaboration and supporting continued grow…
MainStreet Bancshares, Inc. announced strong financial results for Q2 2026, with net income up 14% from the prior quarter, earnings per share of $0.58, increased net interest margin of 3.53%, and successful share repurchases driving tangible book value to $26.30 per share. Loan growth and deposits remained robust, maintaining a healthy 100% loan-to…
Samsung Bioepis and Harrow presented interim post-marketing surveillance results demonstrating that SB11, a biosimilar to Lucentis, provides comparable safety and clinical effectiveness in both treatment-naïve and switched patients with retinal diseases. The real-world study reinforces confidence for retina specialists in using SB11 as a cost-effec…
Monopar Therapeutics announced the addition of experienced commercial executives to its leadership team and board as it prepares for the planned mid-2026 FDA New Drug Application submission and potential market launch of ALXN1840, a novel treatment for Wilson disease. The appointments aim to strengthen the company's commercial capabilities in antic…
Gray Media, Inc. announced that its investigative team InvestigateTV and New Orleans station WVUE FOX 8 received four Sigma Delta Chi Awards for outstanding journalism, recognizing impactful reporting on healthcare inequities, police interrogation tactics, breaking news coverage, and local government investigations. These honors underscore Gray's c…
VCI Global Limited announced that it has regained compliance with Nasdaq periodic filing requirements following a delayed filing of its Annual Report for the fiscal year ended December 31, 2025. The company filed the required report on July 15, 2026, after which Nasdaq confirmed compliance was restored. Management emphasized commitment to corporate…
Belite Bio announced additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant, an oral therapy targeting Stargardt disease type 1 (STGD1). The data presented at the 2026 ASRS Annual Meeting demonstrated stabilization of quantitative autofluorescence—a marker of toxic bisretinoid accumulation—suggesting the drug's rob…
SunPower Inc. announced the successful completion of a 977-kilowatt solar energy system at the Millenium Project in Palm Desert, California. The system is expected to generate over 1.6 million kWh annually, backed by a 30-year performance commitment. The project earned SunPower a high Net Promoter Score (NPS) of 90, reflecting strong customer satis…
authID has secured a contract to deploy its biometric identity verification and authentication technology for more than 100,000 employees across a major global retailer's workforce. The solution enhances onboarding security and streamlines account access at the retailer's call centers, addressing increasing fraud challenges in workforce authenticat…
red violet, Inc., trading as RDVT, announced the expansion of its FOREWARN safety intelligence platform into the home healthcare sector. The new offering provides pre-visit household insights and risk information to home healthcare providers and agencies, aiming to improve safety for caregivers who enter unpredictable environments. This service lev…
AmpliTech Group, Inc., a U.S.-based designer and manufacturer of advanced RF and 5G infrastructure systems, announced subscriptions totaling approximately $21.9 million in its Series A Rights Offering. The company plans to use the net proceeds for general corporate purposes including working capital, scaling operations, commercialization, and poten…
Clearmind Medicine Inc., a clinical-stage biotech company focused on non-hallucinogenic neuroplastogen-derived therapeutics, announced filing a patent application in Hong Kong for innovative psychedelic compounds aimed at treating PTSD and other mental health disorders. This strengthens the company's global IP portfolio under its exclusive licensin…
3 E Network Technology Group Limited announced the completion of the architectural design and deployment planning for a custom Edge AI System-on-Chip (SoC) tailored for next-generation smart healthcare and eldercare robots developed in partnership with Aladdin Alaris AI. The custom chip addresses critical real-time responsiveness, privacy complianc…
Nexera Technologies Ltd, via its subsidiary KeepZone AI, has facilitated the first purchase order for RT LTA Systems' SkyStar 180 aerostats from a leading homeland security solutions integrator in Mexico. This milestone validates KeepZone's business development efforts and has resulted in the extension of KeepZone's exclusive representation agreeme…
Standard BioTools announced the filing of a registration statement for its all-stock merger with Treeline Biosciences. The combined company, expected to operate as Treeline Biosciences Holdings, Inc. under the ticker TRLN, will have over $900 million in cash at closing to fund operations through 2029. Treeline brings a deep clinical-stage pipeline …
BrainsWay Ltd., a leader in noninvasive brain stimulation technologies, announced a $3 million minority equity investment in Radial Health, Inc., a company supporting a network of Brain Medicine clinics. This investment supports Radial's Series A financing and its plan to expand clinical infrastructure, reimbursement tools, and AI-based decision su…
Dyne Therapeutics announced FDA acceptance of its Biologics License Application for z-rostudirsen, an investigational treatment for Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. The FDA granted Priority Review with a target decision date of January 21, 2027. Z-rostudirsen demonstrated significant dystrophin production increases an…
Frontier Nuclear and Minerals Inc. announced the appointment of Joshua Girnun and Donal Carroll to its Board of Directors ahead of its August 2026 annual meeting. These appointments aim to bring enhanced expertise in metals and mining investment, corporate finance, and public company governance to support Frontier's growth in the nuclear fuel cycle…
IREN Limited announced a significant increase in its 2026 AI Cloud annualized run-rate revenue target from $3.7 billion to over $4 billion, backed by $2.8 billion in new multi-year cloud services contracts with leading AI developers including Microsoft and NVIDIA. The company's AI Cloud capacity is scaling rapidly, supported by strong customer dema…
VERAXA Biotech AG announced it received favorable Scientific Advice from the German Paul-Ehrlich-Institute regarding the biology and non-clinical development plan of its advanced BiTAC-TCE cancer therapy candidate. This early regulatory endorsement validates the novel dual-targeting therapy approach, de-risking the development path and supporting e…
